No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
Charmacy Pharmaceutical Co., Ltd. serves as a prominent distributor of pharmaceutical products across the People's Republic of China. The company's comprehensive portfolio includes Western medications, traditional Chinese patent medicines, and various healthcare items, along with associated advisory services. These are supplied to both wholesale distributors and retail pharmacies. Furthermore, Charmacy operates "Charmacy e-Medicine," its proprietary B2B digital platform, which enables clients to efficiently place orders, make inquiries, and process payments online. Founded in 1984, the firm maintains its headquarters in Shantou, PRC. It was formerly known as Chuangmei Pharmaceutical Co., Ltd. until its official renaming to Charmacy Pharmaceutical Co., Ltd. in July 2016.
www.chmyy.comNo one on the platform currently holds 2289.HK.
No tracked institution reports a position in 2289.HK as of their last filing.
No one on the platform has traded 2289.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 2.5% | 3.7% | 5.4% | — | — | — |
| Rev. Growth % | -1.1% | 1.9% | ||||
| Profit Margin % | 1.1% | 1.2% | 1.2% | |||
| Free Cash Flow Margin % | 6.0% | 0.9% | -0.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $5.3B | +22.8% | $0.62 | $0.62–$0.62 | — | 1 |
| 2027 | $6.3B | +17.4% | $0.80 | $0.80–$0.80 | — | 1 |
| 2028 | $7.4B | +17.5% | $0.97 | $0.97–$0.97 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 2289.HKCharmacy Pharmaceutical Co., Ltd. | $5.50 | -0.09% | $593M | — |
| 1011.HKChina NT Pharma Group Company Limited | $0.36 | +0.00% | $236M | — |
| 1612.HKVincent Medical Holdings Limited | $0.67 | +0.00% | $436M | — |
| 1643.HKModern Chinese Medicine Group Co., Ltd. | $0.77 | -0.65% | $551M | — |
| 1652.HKFusen Pharmaceutical Company Limited | $0.85 | +6.25% | $628M | — |
| 1942.HKMOG Digitech Holdings Limited | $0.07 | +1.41% | $107M | — |
| 2325.HKYunkang Group Limited | $0.47 | -3.09% | $275M | — |
Source: Financial Modeling Prep · peers by sector/industry